- Home
- WMS vs ROIV Comparison
WMS vs ROIV Comparison
Compare WMS & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMS
- ROIV
- Stock Information
- Founded
- WMS 1966
- ROIV 2014
- Country
- WMS United States
- ROIV United Kingdom
- Employees
- WMS N/A
- ROIV N/A
- Industry
- WMS Containers/Packaging
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- WMS Consumer Discretionary
- ROIV Health Care
- Exchange
- WMS Nasdaq
- ROIV Nasdaq
- Market Cap
- WMS 8.6B
- ROIV 8.4B
- IPO Year
- WMS 2014
- ROIV N/A
- Fundamental
- Price
- WMS $108.18
- ROIV $10.38
- Analyst Decision
- WMS Strong Buy
- ROIV Strong Buy
- Analyst Count
- WMS 8
- ROIV 6
- Target Price
- WMS $164.25
- ROIV $17.10
- AVG Volume (30 Days)
- WMS 683.3K
- ROIV 6.9M
- Earning Date
- WMS 05-15-2025
- ROIV 02-10-2025
- Dividend Yield
- WMS 0.59%
- ROIV N/A
- EPS Growth
- WMS N/A
- ROIV N/A
- EPS
- WMS 5.98
- ROIV N/A
- Revenue
- WMS $2,942,324,000.00
- ROIV $122,585,000.00
- Revenue This Year
- WMS $3.60
- ROIV N/A
- Revenue Next Year
- WMS $5.44
- ROIV N/A
- P/E Ratio
- WMS $18.08
- ROIV N/A
- Revenue Growth
- WMS 3.67
- ROIV 140.04
- 52 Week Low
- WMS $101.90
- ROIV $9.96
- 52 Week High
- WMS $184.27
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- WMS 41.50
- ROIV 42.16
- Support Level
- WMS $106.17
- ROIV $10.63
- Resistance Level
- WMS $113.69
- ROIV $11.42
- Average True Range (ATR)
- WMS 3.48
- ROIV 0.36
- MACD
- WMS 0.40
- ROIV -0.02
- Stochastic Oscillator
- WMS 34.03
- ROIV 7.59
About WMS Advanced Drainage Systems Inc.
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe; Infiltrator; International and Allied Products and Other. It generates maximum revenue from the Pipe segment. The company serves Agriculture; Aviation and Military; Mining; Residential; Transportation; Healthcare and Education and others.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.